Zhejiang Shengda Bio-Pharm Co., Ltd.SSE: 603079

Indicative Announcement on Proposed Provision for Asset Impairment

Jan 23, 2026 · Issued by Zhejiang Shengda Bio-Pharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 23, 2026 · 2 pages · Chinese

On 6ix: 6ix.com/news/indicative-announcement-on-proposed-provision-for-asset-impairment-1

Release

Indicative Announcement on Proposed Provision for Asset Impairment

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Shengda Bio-Pharm Co., Ltd. on 6ix

Earlier from Zhejiang Shengda Bio-Pharm

Announcement on Completing Industrial and Commercial Change RegistrationJan 13
Announcement on Changing Signatory Certified Public AccountantDec 30, 2025
Announcement on Lifting of Trading Restrictions for Restricted Shares Issued to Specific ObjectsDec 19, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025Dec 16, 2025
Announcement on Progress in Idle Raised Funds Used for Cash ManagementDec 13, 2025

Later from Zhejiang Shengda Bio-Pharm

Announcement on Shareholding Reduction Plan for ShareholdersJan 27
Announcement on Estimated Daily Related Party Transactions in 2026Feb 11
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% ScaleMar 17
Announcement on Redemption at Maturity of Idle Raised Funds Used for Cash ManagementMar 31
Announcement on Progress in Using Idle Raised Funds for Cash ManagementApr 15

All Zhejiang Shengda Bio-Pharm news releases

Follow Zhejiang Shengda Bio-Pharm into a list and get an email when it puts out news.

Follow Zhejiang Shengda Bio-Pharm